Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bsp017
    Member
    • Jul 2013
    • 16

    #1

    SMRT portal errors

    Hi,

    I'm trying to assemble six SMRT cells de novo on the SMRT portal. I tried HGAP.2 and HGAP.3 but both fail with different errors:

    CeleraAssembler/runCaHgap Failed - for HGAP.2
    AssembleUnitig/runCaToUnitig Failed - for HGAP.3

    I'm running SMRT portal through Amazon Web Services.

    On the PacBio github it provides troubleshooting information for the SMRT pipe but I'm unsure how to access this through AWS.

    Any information on how to troubleshoot this would be much appreciated.

    James
  • rhall
    Senior Member
    • Aug 2012
    • 324

    #2
    They are both essentially the same failure. What size amazon instance are you running, in particular memory?
    This failure will arise if <16gb of memory is available.

    Comment

    • bsp017
      Member
      • Jul 2013
      • 16

      #3
      Its an m3.large instance, with 7.5 GB memory. I guess I need a bigger instance.

      Comment

      • bsp017
        Member
        • Jul 2013
        • 16

        #4
        Hello rhall and others,

        I changed to a m3.2xlarge instance, with 30 GB of RAM and assembled my two genomes into 1 and 3 contigs. They both have a QV score just under 50.

        I uploaded the polished assemblies fasta files to use as a reference and I now want to use the reseqeuncing program to wrap up the assemblies, but when I use this tool I get an error saying: 'Failed to submit job'. The error appears usually after several hours.

        I also get this error when I try the Modification and Motif analysis.

        Is there a way around this?

        Thanks,

        James

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...